207 related articles for article (PubMed ID: 12766603)
1. Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma.
Garin E; Laffont S; Rolland Y; Olivie D; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P
Nucl Med Commun; 2003 Jun; 24(6):671-8. PubMed ID: 12766603
[TBL] [Abstract][Full Text] [Related]
2. Radiation exposure and radiation protection of the physician in iodine-131 Lipiodol therapy of liver tumours.
Risse JH; Ponath C; Palmedo H; Menzel C; Grünwald F; Biersack HJ
Eur J Nucl Med; 2001 Jul; 28(7):914-8. PubMed ID: 11504090
[TBL] [Abstract][Full Text] [Related]
3. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary?
Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response.
Brans B; Bacher K; Vandevyver V; Vanlangenhove P; Smeets P; Thierens H; Dierckx RA; Defreyne L
Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167
[TBL] [Abstract][Full Text] [Related]
5. Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment.
Lepareur N; Laffont S; Ardisson V; Noiret N; Garin E
Nucl Med Commun; 2012 Feb; 33(2):205-8. PubMed ID: 22124362
[TBL] [Abstract][Full Text] [Related]
6. Dose to fingertips of staff preparing stranded iodine-125 seeds for permanent prostate implants.
van Haaren PM; van't Riet A; Moerland MA; Koedooder C; Westendorp H
Radiat Prot Dosimetry; 2011 Apr; 145(1):61-5. PubMed ID: 21112885
[TBL] [Abstract][Full Text] [Related]
7. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
[TBL] [Abstract][Full Text] [Related]
8. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
[TBL] [Abstract][Full Text] [Related]
9. Radiation protection in radiosynovectomy of the knee.
Liepe K; Andreeff M; Wunderlich G; Kotzerke J
Health Phys; 2005 Aug; 89(2):151-4. PubMed ID: 16010126
[TBL] [Abstract][Full Text] [Related]
10. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
[TBL] [Abstract][Full Text] [Related]
11. Finger doses for staff handling radiopharmaceuticals in nuclear medicine.
Pant GS; Sharma SK; Rath GK
J Nucl Med Technol; 2006 Sep; 34(3):169-73. PubMed ID: 16951286
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL
J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
[TBL] [Abstract][Full Text] [Related]
13. Radiation dose to PET technologists and strategies to lower occupational exposure.
Roberts FO; Gunawardana DH; Pathmaraj K; Wallace A; U PL; Mi T; Berlangieri SU; O'Keefe GJ; Rowe CC; Scott AM
J Nucl Med Technol; 2005 Mar; 33(1):44-7. PubMed ID: 15731021
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
[TBL] [Abstract][Full Text] [Related]
15. External radiation exposure of personnel in nuclear medicine from 18F, 99mTC and 131I with special reference to fingers, eyes and thyroid.
Leide-Svegborn S
Radiat Prot Dosimetry; 2012 Apr; 149(2):196-206. PubMed ID: 21571739
[TBL] [Abstract][Full Text] [Related]
16. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
[TBL] [Abstract][Full Text] [Related]
17. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
[No Abstract] [Full Text] [Related]
18. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
Rai R; Rai S
Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
[No Abstract] [Full Text] [Related]
19. Effect of a 188 Re-SSS lipiodol/131I-lipiodol mixture, 188 Re-SSS lipiodol alone or 131I-lipiodol alone on the survival of rats with hepatocellular carcinoma.
Garin E; Rakotonirina H; Lejeune F; Denizot B; Roux J; Noiret N; Mesbah H; Herry JY; Bourguet P; Lejeune JJ
Nucl Med Commun; 2006 Apr; 27(4):363-9. PubMed ID: 16531923
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
Launois B; Maddern G
Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
[No Abstract] [Full Text] [Related]
[Next] [New Search]